Tech Group will manufacture and assemble a complex injectable device for the diabetes market and will begin full-scale production in 2015. The device will be shipped to the customer’s European filling site for final assembly.
Don O’Callaghan, vice president and general manager of Tech Group Europe, said, “This expansion reinforces the commitment to developing the Dublin capability as part of an ongoing long-term investment plan. This first phase in the expansion comes about as a result of an exciting win with a leading global pharmaceutical partner in the fast-growing diabetes market, and further strengthens West’s position as one of the world’s leading manufacturers of complex medical devices for the pharmaceutical market.”
Tech Group Europe supplies engineering and manufacturing services for complex drug delivery devices and diagnostic solutions for the pharmaceutical and healthcare sectors.